Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ozurdex for Combined Pseudophakic Cystoid Macular Edema and Diabetic Macular Edema After Cataract Surgery

This study has been completed.
Sponsor:
Collaborator:
Allergan
Information provided by:
Northern California Retina Vitreous Associates
ClinicalTrials.gov Identifier:
NCT01284478
First received: January 25, 2011
Last updated: October 3, 2012
Last verified: October 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2012
  Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)